Showing 1 - 3 results of 3 for search 'David P Nichols', query time: 0.02s
Refine Results
-
1
Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis by Kadambari Vijaykumar, Hui Min Leung, Amilcar Barrios, Justin Wade, Heather Y. Hathorne, David P. Nichols, Guillermo J. Tearney, Steven M. Rowe, George M. Solomon
Published 2024-04-01
Article -
2
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial. by Silvia M Caceres, Linda A Sanders, Noel M Rysavy, Katie R Poch, Caroline R Jones, Kyle Pickard, Tasha E Fingerlin, Roland A Marcus, Kenneth C Malcolm, Jennifer L Taylor-Cousar, David P Nichols, Jerry A Nick, Matthew Strand, Milene T Saavedra
Published 2022-01-01
Article -
3
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist by David P. Nichols, Sarah J. Morgan, Michelle Skalland, Anh T. Vo, Jill M. Van Dalfsen, Sachinkumar B.P. Singh, Wendy Ni, Lucas R. Hoffman, Kailee McGeer, Sonya L. Heltshe, John P. Clancy, Steven M. Rowe, Peter Jorth, Pradeep K. Singh, the PROMISE-Micro Study Group
Published 2023-05-01
Article